These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7349780)

  • 1. Tumor markers of the central nervous system.
    Birkmayer GD
    Cancer Detect Prev; 1981; 4(1-4):231-8. PubMed ID: 7349780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor markers of the central nervous system: biological basis and clinical relevance.
    Birkmayer GD
    Cancer Detect Prev; 1983; 6(1-2):317-24. PubMed ID: 6883389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological aspects of experimental brain tumors (review).
    Stavrou D; Bilzer T; Hultén M; Zänker KS; Anzil AP; Haglid KG; Dahme E
    Anticancer Res; 1982; 2(3):151-5. PubMed ID: 6751209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor antigens in astrocytic gliomas.
    Kurpad SN; Zhao XG; Wikstrand CJ; Batra SK; McLendon RE; Bigner DD
    Glia; 1995 Nov; 15(3):244-56. PubMed ID: 8586461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serologic analysis of nitrosourea-induced rat gliomas.
    Pfreundschuh M; Cravioto H; Hochwald G; Ransohoff J
    J Natl Cancer Inst; 1982 Mar; 68(3):501-5. PubMed ID: 6950179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion.
    Izumoto S; Ohnishi T; Arita N; Hiraga S; Taki T; Hayakawa T
    Cancer Res; 1996 Mar; 56(6):1440-4. PubMed ID: 8640837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface antigens of human glioma cells shared with normal adult and fetal brain.
    Wikstrand CJ; Bigner DD
    Cancer Res; 1979 Aug; 39(8):3235-43. PubMed ID: 88260
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Immunological investigations on human brain tumor patients.
    Mahaley MS
    Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anti-tumor antibodies in the blood of patients with gliomas].
    Martin-Achard A; Diserens AC; de Tribolet N; Zander E; Carrel S
    Schweiz Med Wochenschr; 1978 Jun; 108(25):959-62. PubMed ID: 663586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mahaley Clinical Research Award: chemosensitization of glioma through dendritic cell vaccination.
    Yu JS; Luptrawan A; Black KL; Liu G
    Clin Neurosurg; 2006; 53():345-51. PubMed ID: 17380773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response in melanoma and glioma patients: a solubilized melanoma-membrane component as a tool for detecting circulating antibodies.
    Birkmayer GD
    Cancer; 1981 Dec; 48(11):2399-408. PubMed ID: 7296490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of local immunoresistance in glioma.
    Albesiano E; Han JE; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated cytotoxicity and serum-mediated blocking: evidence that their associated determinants on human tumor cells are different.
    Levy NL
    J Immunol; 1978 Sep; 121(3):916-22. PubMed ID: 80433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
    Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
    Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor immune response: what are the roles for gliomas?].
    Dietrich PY
    Rev Neurol (Paris); 2001 Nov; 157(11 Pt 1):1339-48. PubMed ID: 11924003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific cytotoxic activity of T lymphocyte clones derived from a patient with gliosarcoma immunomodulatory effect of interferons on tumor-associated antigen].
    Miyatake S
    Nihon Geka Hokan; 1988 Jan; 57(1):55-68. PubMed ID: 3138955
    [No Abstract]   [Full Text] [Related]  

  • 18. Partial characterization of nervous system-specific cell surface antigen(s) NS-2.
    Yuan D; Vitetta ES; Schachner M
    J Immunol; 1977 Feb; 118(2):551-7. PubMed ID: 65427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immune response in glioma patients: A solubilized glioma-associated membrane antigen as a tool for detecting circulating antibodies.
    Birkmayer GD; Stass HP
    Int J Cancer; 1980 Apr; 25(4):445-52. PubMed ID: 6768679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.